The 2023 practitioner's toolkit for managing menopause

SR Davis, S Taylor, C Hemachandra, K Magraith… - …, 2023 - Taylor & Francis
Abstract Objective The Practitioner's Toolkit for Managing the Menopause, developed in
2014, provided an accessible desk-top tool for health-care practitioners caring for women at …

[HTML][HTML] Strategies to cope with stress and anxiety during the menopausal transition

P Stute, S Lozza-Fiacco - Maturitas, 2022 - Elsevier
The menopausal transition is often accompanied by psycho-vegetative symptoms, including
stress and anxiety symptoms. Identifying stress and anxiety and intervening early can have …

A systematic review and critical appraisal of menopause guidelines

C Hemachandra, S Taylor, RM Islam… - BMJ Sexual & …, 2024 - srh.bmj.com
Objective and rationale To identify and appraise current national and international clinical
menopause guidance documents, and to extract and compare the recommendations of the …

The impact of micronized progesterone on cardiovascular events–a systematic review

LM Kaemmle, A Stadler, H Janka, M von Wolff… - Climacteric, 2022 - Taylor & Francis
Biologically identical menopausal hormone therapy (MHT) including micronized
progesterone (MP) has gained much attention. We aimed to assess the impact of MP in …

Care reality of menopausal women in Germany: healthcare research using quantitative (SHI claims data) and qualitative (survey) data collection

P Stute, H Eversheim, D Ortius-Lechner, M May… - Archives of gynecology …, 2022 - Springer
Purpose The transition from the fertile phase of life to menopause is associated with
numerous physical changes. Hormone replacement therapy (HRT), as the most effective …

Use of an estradiol transdermal spray in women with menopausal symptoms: a non-interventional study

P Hadji, JO Schmeißer, K Peters, E Göckeler-Leopold - Climacteric, 2024 - Taylor & Francis
Objective This study aimed to investigate the effectiveness, tolerability and application of
estradiol metered-dose transdermal spray (EMDTS) in postmenopausal women during real …

[HTML][HTML] An effective non-hormonal option with high tolerability for mild to moderate symptoms of vaginal dryness associated with menopause

S Eichler, M Panz, A Harder, C Masur, M Häuser… - Maturitas, 2024 - Elsevier
Objectives The efficacy and tolerability of a non-hormonal pessary (that forms an oil-in-water
emollient with the vaginal fluid) were assessed for the treatment of symptoms of vaginal …

Hormone replacement therapy in surgical menopause after gynecological malignancies

DT Naglić, A Mandić, M Zirojević, N Vuković… - Biomolecules and …, 2025 - bjbms.org
This review examines hormone replacement therapy (HRT) in cases of surgical menopause
following gynecological malignancies. It aims to capture current knowledge, summarize …

Особливості оптимальної негормональної терапії вегетативних розладів у жінок у період постменопаузи

DH Konkov, ОА Taran, VO Rud… - REPRODUCTIVE …, 2022 - reproduct-endo.com
Objectives: to evaluate the clinical effectiveness of the Vitae-Melatonin in the complex
treatment of vegetative disorders in postmenopausal women. Materials and methods. The …

Efficacy and safety of personalized menopausal hormone therapy: a review of international guidelines

SV Yureneva - Obstetrics and Gynecology, 2024 - journals.eco-vector.com
As the trend towards increasing life expectancy in developed and develo** countries
continues, and the speed and scale of demographic change in the world increase, there is a …